OOIR: Observatory of International Research

Papers

(The H4-Index of Annals of Clinical and Translational Neurology is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”	409
Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients	341
Blood neurofilament light: a critical review of its application to neurologic disease	128
DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France	86
Anakinra usage in febrile infection related epilepsy syndrome: an international cohort	79
Repeat expansion scanning of the NOTCH2NLC gene in patients with multiple system atrophy	67
Long COVID‐19: Objectifying most self‐reported neurological symptoms	65
Longitudinal biomarkers in amyotrophic lateral sclerosis	62
De Novo Status Epilepticus in patients with COVID‐19	59
Serious safety events in rituximab‐treated multiple sclerosis and related disorders	57
Neurological manifestations of coronavirus infections – a systematic review	56
Natural history of Type 2 and 3 spinal muscular atrophy: 2‐year NatHis‐SMA study	55
Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes	54
Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID‐19	51
Viltolarsen in Japanese Duchenne muscular dystrophy patients: A phase 1/2 study	51
Seizures and risk of epilepsy in anti‐NMDAR, anti‐LGI1, and anti‐GABA_BR encephalitis	49
Brain dysfunction in COVID‐19 and CAR‐T therapy: cytokine storm‐associated encephalopathy	49
Retraining and control therapy for pediatric psychogenic non‐epileptic seizures	49
Improved ALS clinical trials through frequent at‐home self‐assessment: a proof of concept study	48
230 days of ultra long‐term subcutaneous EEG: seizure cycle analysis and comparison to patient diary	46
Insular and occipital changes in visual snow syndrome: a BOLD fMRI and MRS study	45
Comparison of Simoa^TM and Ella^TM to assess serum neurofilament‐light chain in multiple sclerosis	44
Cortical hyperexcitability evolves with disease progression in ALS	44
Experiences of telemedicine in neurological out‐patient clinics during the COVID‐19 pandemic	43
Centromedian thalamic responsive neurostimulation for Lennox‐Gastaut epilepsy and autism	43

Diaphragm dysfunction in severe COVID‐19 as determined by neuromuscular ultrasound	42
Detection of prions in skin punch biopsies of Creutzfeldt–Jakob disease patients	42
Role of homocysteine in the development and progression of Parkinson’s disease	41
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease	41
Long‐term peripheral immune cell profiling reveals further targets of oral cladribine in MS	39
The A4 study: β‐amyloid and cognition in 4432 cognitively unimpaired adults	39
A rapid α‐synuclein seed assay of Parkinson’s disease CSF panel shows high diagnostic accuracy	39
Evolution of neurologic symptoms in non‐hospitalized COVID‐19 “long haulers”	38
Neuronal intranuclear inclusion disease is genetically heterogeneous	38
Dopamine transporter imaging predicts clinically‐defined α‐synucleinopathy in REM sleep behavior disorder	37
The brain–heart interaction in epilepsy: implications for diagnosis, therapy, and SUDEP prevention	36
Acute disseminated encephalomyelitis in a patient vaccinated against SARS‐CoV‐2	36
Developmental regression and mitochondrial function in children with autism	36
Re‐defining the clinicopathological spectrum of neuronal intranuclear inclusion disease	36